Collectively, these studies highlight multiple pharmacological strategies to disrupt FSP1 function, including active-site inhibition, species-selective targeting and structure-guided inhibitor development
PubMed Central , Journal of the American College of Nutrition , vol
Every month that goes by I am more results
As we age, our natural production of glutathione tends to decline, making it essential to explore ways to boost its levels in our bodies
It belongs to a class of medications called GLP-1 receptor agonists
Therefore, further studies on the development of selective inhibitors of the mitochondrial SLC1A5 variant are needed and should help to establish whether the level of the SLC1A5 variant is a predictive marker of glutamine dependency in cancer 21